Gyre Therapeutics Inc (GYRE)

Stock-Based Compensation

$7.82M

TTM · Period ending: · USD

GYRE logo

GYRE Stock-Based Compensation

Latest reported$7.82M
GYRE Stock-Based Comp ($0.00 → $7.82M)
High-resolution chart · PNG

GYRE stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
7,157,000
831,000
7,281,000
13,366,000
3,405,000
3,627,000
3,204,000
2,606,000
863,000
635,000
326,000
3,472,000
5,216,000
7,846,000
8,513,000
4,937,000
2,454,000
2,065,000
2,746,705,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.